Capricor Therapeutics (United States)
We offer a multi-stage pipeline exploring allogeneic cardiosphere-derived cells (CDCs) and exosome science for novel therapeutic approaches to treat a broad range of serious diseases. Capricor’s science is focused on cell and exosome-based biology, offering multiple modalities allowing us to create a new class of therapeutic medicines for patients.
Basic Information
- Category: pharmaceutical industry
- Website: http://capricor.com/
Documented Facts
- Industry (Wikidata; date unspecified): pharmaceutical industry (Source 5: Wikidata Q36875411, revision 2474511760; Source 6: Wikidata label: Q507443, revision 2542338100)
- Country (Wikidata; date unspecified): United States (Source 5: Wikidata Q36875411, revision 2474511760; Source 7: Wikidata label: Q30, revision 2556188301)
Evidence and Sources
- Capricor Therapeutics (United States) — Official Site (official)
- Capricor Therapeutics (United States) on instagram (social)
- Capricor Therapeutics (United States) on facebook (social)
- Capricor Therapeutics (United States) on linkedin (social)
- Wikidata Q36875411, revision 2474511760 (knowledge-base)
- Wikidata label: Q507443, revision 2542338100 (knowledge-base)
- Wikidata label: Q30, revision 2556188301 (knowledge-base)
Citation Guidance
Explore pharmaceutical industry profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Capricor Therapeutics (United States).
- Canonical profile: https://brandsource.ai/brands/capricor-therapeutics-united-states
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/capricor-therapeutics-united-states/json-ld
- Citation profile API: https://brandsource.ai/api/brands/capricor-therapeutics-united-states/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (88/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
We offer a multi-stage pipeline exploring allogeneic cardiosphere-derived cells (CDCs) and exosome science for novel therapeutic approaches to treat a broad range of serious diseases. Capricor’s science is focused on cell and exosome-based biology, offering multiple modalities allowing us to create a new class of therapeutic medicines for patients.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 6 supporting sources linked.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.